Faculty

Institution

Unit

Venue

Maria E. Cabanillas

Professor Assistant Professor

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Endocrine Neoplasia And Hormonal Disorders

Department Of Endocrine Neoplasia And Hormonal Disorders And The Children'S Cancer Hospital

The University of Texas MD Anderson Cancer Center

Maria E. Cabanillas is a Professor at The University of Texas MD Anderson Cancer Center. Her research focuses on thyroid oncology, specifically anaplastic thyroid carcinoma (ATC), targeted therapies for ALK and BRAF mutations, and prognostic gene signatures for papillary thyroid carcinoma. Recent publications include a case report on lorlatinib and pemetrexed for ALK fusion-positive ATC, a graded prognostic assessment for brain metastases derived from a 10,306-patient cohort, and the PRECISE gene signature. She has contributed to ASCO guidelines on systemic thyroid cancer treatment and investigates immunotherapy combinations, including lenvatinib plus pembrolizumab.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Maria E. Cabanillas

The University of Texas MD Anderson Cancer Center

Professor Assistant Professor

You can click a keyword to filter the displayed items

oncology thyroid cancer research radiation oncology thyroid disease cancer treatment pathology pharmacology medicine tumor biology oncogenes cancer care therapeutic targets medicinal research endocrine oncology molecular cancer cancer immunotherapy surgical oncology cancer biology clinical research endocrinology cancer genetics anti-cancer agents pharmacotherapy cancer cells tumor targeting thyroid cancer metastasis cancer discovery molecular diagnostics cancer management anaplastic thyroid carcinoma cancer genomics endocrine-related cancers neck oncology cancer imaging cellular therapy anaplastic thyroid cancer leukemia thyroid hormone medical mycology radiation therapy cytopathology oncogenic agent clinical radiation oncology vascular biology novel therapies immune checkpoint inhibitors enzyme inhibition treatment and prevention tumor heterogeneity melanoma hematological malignancies next-generation sequencing therapeutic efficacy radiopharmaceutical therapy disease progression phase ii trial advanced thyroid cancer cancer growth oncologic imaging cohort studies otorhinolaryngology differentiated thyroid cancer targeted therapy metastatic thyroid cancer liver cancer somatic variant tyrosine kinase inhibitors phase ii study thyroid cancers thyroid carcinoma acute lymphocytic leukemia genomic alterations ret-altered cancers induction chemotherapy

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 2709: Precise: A Prognostic Thyroid Follicular Cell-Derived Gene Signature for Papillary Thyroid Carcinoma.. Cancer Research (2026)

pathologyendocrine oncologythyroid diseasecarcinogenesiscancer researchabstract 2709papillary thyroid carcinomathyroid

A Differentiated Thyroid Carcinoma-Specific Graded Prognostic Assessment for Brain Metastases: Derivation in a 10,306-Patient Cohort and External Validation. Journal of Neuro-Oncology (2026)

clinical radiation oncologyneurologymetastasiscancer carebrain tumor researchthyroid diseaseradiologyexternal validationcancer researchbrain metastasesdifferentiated thyroid carcinoma-specificthyroidoncologyneuro-oncology

Deceptive Thyroid Pathologies: Anaplastic Thyroid Carcinoma Mimics and Clinical Implications. Head & Neck (2026)

thyroidendocrine oncologydeceptive thyroid pathologiesthyroid disease

Real-World Experience With Lenvatinib Plus Pembrolizumab in Metastatic Braf Wild-Type Anaplastic Thyroid Carcinoma. Thyroid (2026)

metronomic therapymetastasispathologyradiation oncologyreal-world experiencemolecular cancerthyroid diseasecancer treatmentthyroidoncology

Sustained Response to Lorlatinib and Pemetrexed in Alk Fusion–Positive Anaplastic Thyroid Carcinoma With Multiple Distant Metastases: A Case Report. JCO Precision Oncology (2026)

multiple distantoncogenesmetastasispathologyradiation oncologycase reportmolecular cancerthyroid diseasejama oncologycancer treatmentcancer letterthyroidoncology

Systemic Treatment of Thyroid Cancer: Asco Guideline. Journal of Clinical Oncology (2026)

thyroidmedicinecancer treatmentcancer careoncology

1338 Multi-Cohort Phase II Study of Autologous Centrally Manufactured Tumor Infiltrating Lymphocytes. (2025)

immunophenotypingpathologyimmunologycell transplantationimmunotherapycellular therapytumor microenvironmentlymphoid neoplasiaoncology

Abstract 4358317: Emergence of Hypertension in Thyroid Cancer Patients on Braf ± Mek Inhibitors: A Closer Look at Incidence and Contributing Risk Factors. Circulation (2025)

tumor biologyoncologymolecular cancerthyroid diseasethyroid cancer patientscontributing risk factorsantihypertensive therapymedicinepharmacologytherapeutic targetsabstract 4358317thyroidhypertension

Abstract 4756: Novel Anaplastic Thyroid Carcinoma Patient-Derived Xenograft Models and Cell Line. Cancer Research (2025)

oncogenespathologycell linetumor biologyendocrine oncologycell biologymolecular cancerthyroid diseasecancer researchcancer cellsthyroidoncologyabstract 4756

Abstract Lb414: Characterization of the Genomic Landscape of Braf -, Ras -, and Fusion-Negative Thyroid Carcinomas Underscores the Role of Tumor Suppressor Genes. Cancer Research (2025)

oncogenespathologygenomic landscapetumor biologycancer biologycell biologymolecular cancerthyroid diseasecarcinogenesismolecular diagnosticstumor suppressorscancer geneticscancer genomicstumor suppressor genescancer letterthyroidabstract lb414genetics

1
2
3
4
5
35
10 / page

Maria E. Cabanillas

Professor Assistant Professor

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Endocrine Neoplasia And Hormonal Disorders

Department Of Endocrine Neoplasia And Hormonal Disorders And The Children'S Cancer Hospital

The University of Texas MD Anderson Cancer Center

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Maria E. Cabanillas

The University of Texas MD Anderson Cancer Center

Professor Assistant Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract 2709: Precise: A Prognostic Thyroid Follicular Cell-Derived Gene Signature for Papillary Thyroid Carcinoma.. Cancer Research (2026)

pathologyendocrine oncologythyroid diseasecarcinogenesiscancer researchabstract 2709papillary thyroid carcinomathyroid

A Differentiated Thyroid Carcinoma-Specific Graded Prognostic Assessment for Brain Metastases: Derivation in a 10,306-Patient Cohort and External Validation. Journal of Neuro-Oncology (2026)

Deceptive Thyroid Pathologies: Anaplastic Thyroid Carcinoma Mimics and Clinical Implications. Head & Neck (2026)

thyroidendocrine oncologydeceptive thyroid pathologiesthyroid disease

Real-World Experience With Lenvatinib Plus Pembrolizumab in Metastatic Braf Wild-Type Anaplastic Thyroid Carcinoma. Thyroid (2026)

metronomic therapymetastasispathologyradiation oncologyreal-world experiencemolecular cancerthyroid diseasecancer treatmentthyroidoncology

Sustained Response to Lorlatinib and Pemetrexed in Alk Fusion–Positive Anaplastic Thyroid Carcinoma With Multiple Distant Metastases: A Case Report. JCO Precision Oncology (2026)

multiple distantoncogenesmetastasispathologyradiation oncologycase reportmolecular cancerthyroid diseasejama oncologycancer treatmentcancer letterthyroidoncology

Systemic Treatment of Thyroid Cancer: Asco Guideline. Journal of Clinical Oncology (2026)

thyroidmedicinecancer treatmentcancer careoncology

1338 Multi-Cohort Phase II Study of Autologous Centrally Manufactured Tumor Infiltrating Lymphocytes. (2025)

immunophenotypingpathologyimmunologycell transplantationimmunotherapycellular therapytumor microenvironmentlymphoid neoplasiaoncology

Abstract 4358317: Emergence of Hypertension in Thyroid Cancer Patients on Braf ± Mek Inhibitors: A Closer Look at Incidence and Contributing Risk Factors. Circulation (2025)

tumor biologyoncologymolecular cancerthyroid diseasethyroid cancer patientscontributing risk factorsantihypertensive therapymedicinepharmacologytherapeutic targetsabstract 4358317thyroidhypertension

Abstract 4756: Novel Anaplastic Thyroid Carcinoma Patient-Derived Xenograft Models and Cell Line. Cancer Research (2025)

oncogenespathologycell linetumor biologyendocrine oncologycell biologymolecular cancerthyroid diseasecancer researchcancer cellsthyroidoncologyabstract 4756

Abstract Lb414: Characterization of the Genomic Landscape of Braf -, Ras -, and Fusion-Negative Thyroid Carcinomas Underscores the Role of Tumor Suppressor Genes. Cancer Research (2025)

1
2
3
4
5
35
10 / page